Brief: Sprint Bioscience Q4 Operating Loss Widens To SEK 10.8 Mln
Feb 20 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q4 OPERATING RESULTS AT -10,8 (-7,2) MSEK
* Q4 NET INCOME AT 0,2 (2,9) MSEK
Source text for Eikon: ID:nWkr79sv4J
Further company coverage: SPRINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program